Zhou Zhou

Education

M.S., epidemiology, Harvard T.H. Chan School of Public Health; B.S., biological sciences, Peking University

Summary of Experience

Ms. Zhou’s expertise is in health economics and outcomes research (HEOR) consulting. She uses statistical and econometric models to support health care decision making across a range of disease areas, including oncology, hematology, rheumatology, and psychiatry. Ms. Zhou has extensive experience conducting studies of comparative effectiveness and cost effectiveness, budget impact analyses, treatment patterns, and burden-of-illness issues. Her work has involved a variety of data types, including administrative claims, clinical trials, patient records, physician surveys, and medical literature. She has presented her research at international conferences and published it in peer-reviewed journals.

Selected Publishing

• Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer

  Journal of Medical Economics. 2019 Feb;22(2):140-150
  2019

  Signorovitch J, Zhou Z, Ryan J, Anhorn R, Chawla A

  Health Care
• Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis

  Advances in Therapy, 2019
  2019

  Zhou Z, Fan Y, Thomason D, Tang W, Liu X, Zhou ZY, Macaulay D, Fischer A

  Health Care
• Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States

  The Journal of Rheumatology, 2019
  2019

  Zhou Z, Fan Y, Tang W, Liu X, Thomason D, Zhou ZY, Macaulay D, Fischer A

  Health Care
• Treatment patterns among adults with ADHD receiving long-acting therapy

  American Journal of Managed Care. Jul 2018;24(8 Spec No.):SP329-SP337
  2018

  Zhou Z, Zhou ZY, Kellar SS, Sikirica V, Xie J, Grebla R

  Health Care
• Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States

  Current Medical Research and Opinion. Apr 2018;34(4):585-592
  2018

  Zhou Z, Zhou ZY, Kelkar SS, Sikirica V, Xie J, Grebla R

  Health Care
• Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study

  JCO Precision Oncology, November 2, 2018
  2018

  Chawla A; Janku F; Wheler J; Miller V; Ryan J; Anhorn, R; Zhou Z; Signorovitch J

  Health Care
• Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer: A Network Meta-analysis

  Clinical Therapeutics. Apr 2018;40(4):628-639 e623
  2018

  Ayyagari R, Tang D, Patterson-Lomba O, Zhou Z, Xie J, Chandiwana D, Dalal AA, Niravath PA

• Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States

  Journal of Attention Disorders, July 1, 2018
  2018

  Zhou Z, Betts KA, Bocharova I, Kinrich D, Spalding WM

  Health Care
• Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis

  Diabetes Therapy. Mar 29 2018.
  2018

  Jiang R, Law E, Zhou Z, Yang H, Wu EQ, Seifeldin R 

  Health Care
• Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2- Advanced Breast Cancer.

  Advances in Therapy. Dec 2017;34(12):2566-2584
  2017

  Zhou Z, Tang DH, Xie J, Ayyagari R, Wu E, Niravath PA

  Health Care
• Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

  Diabetes Therapy. Jun 2017;8(3):555-571
  2017

  Zhou Z, Chaudhari P, Yang H, Fang AP, Zhao J, Law EH, Wu EQ, Jiang R, Seifeldin R

  Health Care
• Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey

  Clinical Therapeutics, 2016 02; 5(2): 209-220
  2016

  Lin PL, Hao Y, Xie J, Li N, Zhong Y, Zhou Z, Signorovitch JE, Wu EQ.

  Health Care
• Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective

  Current Medical Research and Opinion, Opin 2016 03; 32(3): 405-416. e-pub ahead of print 2015/11/14
  2016

  Nazareth T, Li N, Marynchenko M, Zhou Z, Chopra P, Signorovitch J, Wu E, Ahmed S, Marvel J, Sasane R

• Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

  Aliment Pharmacol Ther. 2014 Jul;40(1):83-92
  2014

  Guerin A, Mody R, Fok B, Lasch KL, Zhou Z, Wu EQ, Zhou W, Talley NJ

  Health Care